Comparison

ONO-0300302 European Partner

Item no. HY-115450-50mg
Manufacturer MedChem Express
CASRN 856689-51-5
Amount 50 mg
Quantity options 100 mg 10 mg 1 mg 25 mg 50 mg 5 mg
Category
Type Chemicals
Specific against other
Purity 99.43
Formula C29H35NO5
Citations [1]Terakado M, et al. Discovery of a Slow Tight Binding LPA1 Antagonist (ONO-0300302) for the Treatment of Benign Prostatic Hyperplasia. ACS Med Chem Lett. 2017 Nov 20;8(12):1281-1286.
Smiles O=C(O)CCC1=CN(C[C@H](CC2CC3=C(C=CC=C3)C2)[C@@H](C4=CC(OC)=C(C)C(OC)=C4)O)C=C1
ECLASS 10.1 32160000
ECLASS 11.0 32160000
UNSPSC 12000000
Available
Product Description
ONO-0300302 is an orally active and potent LPA1 (lysophosphatidic acid receptor 1) antagonist, with an IC50 of 0.086 μM. ONO-0300302 is a slow tight binding inhibitor, and its binding affinity increases with time, with Kd of 0.34 nM (37 °C, 2 h). ONO-0300302 can be used for benign prostatic hyperplasia (BPH) research[1].
StorageTemperature
-20°C (Powder, protect from light)
Shipping
Blue Ice
Manufacturers Applications
Metabolism-protein/nucleotide metabolism
MolecularWeight
477.59
Clinical Information
No Development Reported
Manufacturers Research Area
Cancer; Endocrinology
Solubility
DMSO : 220 mg/mL (ultrasonic)
Target
LPL Receptor
Manufacturers Target
LPL Receptor
Isoform
LPAR1
Manufacturers Pathway
GPCR/G Protein
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 50 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close